Alpha-1 Antitrypsin Deficiency (AATD) Augmentation Therapy Market Size, Share and Industry Analysis by Product Type (Glassia, Aralast NP, Prolastin C, Zemaira/Respreeza), End User (Hospitals, Specialty Clinics) and Regional Forecast, 2019 - 2032

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content:

1. Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

4. Key Insights

4.1 Prevalence of AATD by major countries

4.2 Pricing analysis of available products

4.3 Recent industry developments such as partnerships, mergers & acquisitions

4.4 Regulatory scenario for key countries

5. Global AATD Augmentation Therapy Market Analysis, Insights and Forecast, 2015-2026

5.1. Key Findings / Summary

5.2 Market Analysis, Insights and Forecast – By Product Type

5.2. 1Prolastin C

5.2.2 Glassia

5.2.3 AralastNP

5.2.4 Zemaira/Respreeza

5.3. Market Analysis, Insights and Forecast – By End User

5.3.1 Hospitals

5.3.2 Specialty Clinics

5.3.3 Others

5.4. Market Analysis, Insights and Forecast – By Region

5.4.1 North America

5.4.2 Europe

5.4.3 Asia Pacific

5.4.4 Rest of World

6. North America AATD Augmentation Therapy Market Analysis, Insights and Forecast, 2015-2026

6.1. Key Findings / Summary

6.2. Market Analysis – By Product Type

6.2.1 Prolastin C

6.2.2 Glassia

6.2.3 Aralast NP

6.2.4 Zemaira/Respreeza

6.3. Market Analysis – By End User

6.3.1 Hospitals

6.3.2 Specialty Clinics

6.3.3 Others

6.4. Market Analysis – By Country

6.4.1 U.S.

6.4.3 Canada

7. Europe AATD Augmentation Therapy Market Analysis, Insights and Forecast, 2015-2026

7.1. Key Findings / Summary

7.2. Market Analysis – By Product Type

7.2.1 Prolastin C

7.2.2 Glassia

7.2.3 AralastNP

7.2.4 Zemaira/Respreeza

7.3. Market Analysis – By End User

7.3.1 Hospitals

7.3.2 Specialty Clinics

7.3.3 Others

7.4. Market Analysis – By Country/Sub-region

7.4.1 Germany

7.4.2 U.K.

7.4.3 France

7.4.4 Italy

7.4.5 Spain

7.4.6 Rest of Europe

8. Asia Pacific AATD Augmentation Therapy Market Analysis, Insights and Forecast, 2015-2026

8.1. Key Findings / Summary

8.2. Market Analysis – By Product Type

8.2.1 Prolastin C

8.2.2 Glassia

8.2.3 Aralast NP

8.2.4 Zemaira/Respreeza

8.3. Market Analysis – By End User

8.3.1 Hospitals

8.3.2 Specialty Clinics

8.3.3 Others

8.4. Market Analysis – By Country/Sub-region

8.4.1 India

8.4.2 China

8.4.3 Japan

8.4.4 Australia

8.4.5 Rest of Asia Pacific

9. Rest of World AATD Augmentation Therapy Market Analysis, Insights and Forecast, 2015-2026

9.1. Key Findings / Summary

9.2. Market Analysis – By Product Type

9.2.1 Prolastin C

9.2.2 Glassia

9.2.3 Aralast NP

9.2.4 Zemaira/Respreeza

9.3. Market Analysis – By End User

9.3.1 Hospitals

9.3.2 Specialty Clinics

9.3.3 Others

10. Competitive Analysis

10.1. Key Industry Developments

10.2. Global Market Share Analysis (2018)

10.3. Competition Dashboard

10.4. Comparative Analysis –Major Players

10.5. Company Profiles (Overview,Products & services, SWOT analysis, Recent developments, strategies, financials(based on availability))

10.5.1 Grifols, S.A.

10.5.2 CSL Limited

10.5.3 Shireplc

10.5.4 Kamada Ltd.

11. Strategic Recommendations